INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities for drug discovery teams studying pathway cross-talk ...
STATE COLLEGE, PA, UNITED STATES, January 15, 2026 /EINPresswire.com/ — INDIGO Biosciences, a premier provider of cell-based reporter assay solutions, has announced ...
Agonist dose-response of Human HNF4a. Inverse-Agonist dose-response of Human HNF4a. A New Sensitive, Time-Saving Assay for Preclinical Research of Metabolic Regulation and Disease Pathogenesis STATE ...
New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related Therapeutics STATE COLLEGE, PA, UNITED STATES, March 19, 2026 ...
STATE COLLEGE, PA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — INDIGO Biosciences, a leading provider of cell-based reporter assay solutions, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results